Alle Storys
Folgen
Keine Story von W.O.M. World of Medicine AG mehr verpassen.

W.O.M. World of Medicine AG

euro adhoc: W.O.M. World of Medicine AG
Earnings Forecast
WORLD OF MEDICINE will exceed sales and revenue goals for Fiscal Year 2007

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.
9-month report
26.10.2007
Medical device manufacturer WORLD OF MEDICINE has achieved a revenue 
growth of 16.4% to EUR25.1 million in the first nine month of the 
current business year - despite the adverse Euro/US dollar exchange 
rate. Revenues have increased by 37.0% in the third quarter. Orders 
booked by the end of September 2007 exceeded last year`s September 
figure by EUR3.1 million. Based on these figures and as well as a 
year end projection, the Management Board expects to surpass the 
revenue goal for fiscal year 2007. The Board now anticipates a growth
of revenues of at least 10.0% (before: 4-5%) to more than EUR34.0 
million.
The sales yield before taxes reached 15.6% after the first nine 
month. Therefore, the Management Board raises the forecast for fiscal
year 2007 from originally 10.0% to 13.0%.
WORLD OF MEDICINE will publish the complete 9-month report as 
announced on November 7, 2007.
The Management Board
end of announcement                               euro adhoc 26.10.2007 09:59:34

Further inquiry note:

Stefanie Gehrke
Tel.: +49 (0)30 399 81 566
E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN: DE0006637390
WKN: 663739
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / free trade

Weitere Storys: W.O.M. World of Medicine AG
Weitere Storys: W.O.M. World of Medicine AG